SAMINI KEYVAN 4/A
4/A · MOBIX LABS, INC · Filed Feb 27, 2025
Insider Transaction Report
Form 4/AAmended
MOBIX LABS, INCMOBX
SAMINI KEYVAN
DirectorPresident, CFO & Director
Transactions
- Award
Option (Right to Buy)
2023-12-21+318,029→ 318,029 totalExercise: $0.17Exp: 2030-08-10→ Class A Common Shares (318,029 underlying)
Footnotes (3)
- [F1]On December 26, 2023, the Reporting Person filed a Form 4 that incorrectly reported the acquisition of shares, which should have been reported as the acquisition of options. The Reporting Person does not directly hold any shares of Class A Common Stock.
- [F2]Received in connection with the business combination (the "Business Combination") by and between Chavant Capital Acquisition Corp., CLAY Merger Sub II, Inc. and Mobix Labs, Inc. in accordance with the terms of the Business Combination Agreement dated as of November 15, 2022, which closed on December 21, 2023 ("Closing Date"). At the Closing Date, the Reporting Person acquired these options in exchange for the same number of certain equity interests of Mobix Labs, Inc. held immediately prior to the Closing, which were automatically converted into a number of options exercisable into shares of Class A Common Stock.
- [F3]These options are fully vested and exercisable.